Literature DB >> 27504422

Clinicopathological and Immunohistochemical Characteristics of Verruciform Xanthoma of the Lower Gingiva: A Case Report.

Masashi Kimura1, Hiroyuki Ohto2, Akio Shibata1, Atsushi Enomoto3, Masahiro Umemura4.   

Abstract

Verruciform xanthoma (VX) is a rare benign lesion and mainly effects the oral mucosa. This slow-growing asymptomatic lesion typically develops along the gingival margin of the masticatory mucosa, followed by the hard palate, tongue, buccal mucosa, floor of the mouth, alveolar mucosa, soft palate and junction between the hard and soft palate. Moreover, this lesion can also affect the skin and genital organs. Clinically, VX generally presents a sessile or pedunculated appearance, forming a papule or single plaque with verrucous or papillomatous mucosal growth. The colour (white, pink, grey, or yellow) depends on the thickness of the overlying epidermis. In fact, the clinical findings of VX are similar to those of verrucous carcinoma and other benign tumours, such as squamous papilloma, verruca vulgaris and mucosal fibroma. For this reason, clinical and histopathological examinations are essential for accurate differential diagnosis. Histologically, VX is characterized by parakeratosis, rete ridges of uniform depth and the accumulation of foam cells, which are also called "xanthoma cells". Here, we describe the clinicopathological and immunohistochemical findings of a VX located on the lower gingiva of a 64-year-old male patient.

Entities:  

Keywords:  Immunohistochemistry; Oral cavity; Xanthoma cells

Year:  2016        PMID: 27504422      PMCID: PMC4963782          DOI: 10.7860/JCDR/2016/15446.7950

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  9 in total

1.  Oral verruciform xanthoma: a clinicopathologic and immunohistochemical study of 20 cases.

Authors:  Bruno A B de Andrade; Michelle Agostini; Fábio R Pires; Alicia Rumayor; Román Carlos; Oslei P de Almeida; Mário J Romañach
Journal:  J Cutan Pathol       Date:  2015-06-04       Impact factor: 1.587

Review 2.  Verruciform xanthoma--biological profile of 282 oral lesions based on a literature survey with nine new cases from Japan.

Authors:  H P Philipsen; P A Reichart; T Takata; I Ogawa
Journal:  Oral Oncol       Date:  2003-06       Impact factor: 5.337

3.  Verruciform xanthoma.

Authors:  W G Shafer
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1971-06

4.  Verruciform xanthoma. A clinicopathologic review and report of fifty-four cases.

Authors:  B Nowparast; F V Howell; G M Rick
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1981-06

5.  Oral verruciform xanthoma: a clinicopathologic study of 15 cases.

Authors:  Chuan-Hang Yu; Tung-Chieh Tsai; Jeng-Tzung Wang; Bu-Yuan Liu; Yi-Ping Wang; Andy Sun; Chun-Pin Chiang
Journal:  J Formos Med Assoc       Date:  2007-02       Impact factor: 3.282

Review 6.  Oral verruciform xanthoma associated with chronic graft-versus-host disease: a report of five cases and a review of the literature.

Authors:  Shokoufeh Shahrabi Farahani; Nathaniel S Treister; Zainab Khan; Sook-Bin Woo
Journal:  Head Neck Pathol       Date:  2011-02-09

7.  Verruciform xanthoma of oral cavity- a case report.

Authors:  Shivani Aggarwal; Ashim Aggarwal; Sharanjeet Gill; Yujika Bakshi; Harkanwal Preet Singh
Journal:  J Clin Diagn Res       Date:  2014-07-20

8.  A case of multiple verruciform xanthoma in gingiva.

Authors:  Yuping Qi; Qinfeng Sun; Pishan Yang; Aimei Song
Journal:  Br J Oral Maxillofac Surg       Date:  2013-10-19       Impact factor: 1.651

9.  Cellular basis of verruciform xanthoma: immunohistochemical and ultrastructural characterization.

Authors:  F Ide; K Obara; H Yamada; K Mishima; I Saito; K Kusama
Journal:  Oral Dis       Date:  2008-03       Impact factor: 3.511

  9 in total
  1 in total

Review 1.  Oral verruciform xanthoma: Report of 13 new cases and review of the literature.

Authors:  P Tamiolakis; V-I Theofilou; K-I Tosios; A Sklavounou-Andrikopoulou
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2018-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.